The global macro-environment is evolving rapidly and already affecting decisions about launches, infrastructure investments, asset life-cycle management, trial design and more. Today, everyone in the pharma ecosystem has to be aware of the regulatory, policy and reimbursement changes that affect strategic decision-making. Join us as we dig into the trends that you should have on your radar today.
In this webinar, you’ll learn:
- Regulatory, policy and market access changes coming and their implications for pharma
- Scenarios that will affect decision-making about lead launches (indication and markets) and investment in data and evidence generation infrastructure
- How to plan for the coming changes and revisit your current portfolio strategy, including how to manage asset life cycles and approach business development and licensing